Rat brain phospholipase D1 (rPLD1) belongs to a superfamily defined by the highly conserved catalytic motif (H(X)K(X) 4 D, denoted HKD. RPLD1 contains two HKD domains, located in the N-and C-terminal regions. Deletion mutants of rPLD1 that contained only an N-or C-terminal HKD domain exhibited no catalytic activity when expressed in COS 7 cells. However, when N-terminal fragments containing one of the HKD domains were cotransfected with a C-terminal fragment containing the other HKD domain, PLD activity was restored. Furthermore, immunoprecipitation assays showed that the N-and C-terminal halves of rPLD1 were physically associated when expressed in COS 7 cells. In addition, deletion of 168 amino acids from the N terminus of rPLD1 significantly enhanced basal PLD activity while inhibiting the response to phorbol ester. Likewise, the coexpression of this truncated N-terminal half with the C-terminal half resulted in increased PLD activity. In summary, this study provides direct evidence that the enzymatic activity of rPLD1 requires the presence of the HKD domains in both the N-and C-terminal regions of the molecule. More importantly, the two halves of rPLD1 can associate, and this may be essential to bring the two HKD domains together to form an active catalytic center. These findings provide new insights into the catalytic mechanism of enzymes of the PLD superfamily.
Phospholipase D (PLD) 1 catalyzes the hydrolysis of phosphatidylcholine to phosphatidic acid and choline (1) . It also carrys out a phosphatidyl transfer reaction which is used as a specific measure of PLD activity (2) . PLD activity has been detected in almost all organisms and is involved in a variety of signal transduction cascades (3, 4) . PLD activity has been shown to be regulated by small G proteins, PKC, proteintyrosine kinases, and intracellular Ca 2ϩ. It was first cloned from plant (5) followed by yeast (6) . To date, two types of mammalian PLD genes, termed PLD1 and PLD2, have been cloned (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . PLD1 has a low basal activity and responds to PKC and small G protein of the ADP-ribosylation factor and Rho families. On the other hand, PLD2 is constitutively active and shows little response to stimuli.
Data base searches using PLD1 and other sequences reveal that PLD belongs to a superfamily (17) (18) (19) with four highly conserved regions (17) . The most prominent conserved sequences reside in regions I and IV and contain the invariant motif, HXK(X) 4 D, denoted HKD. The HKD motif is found in other enzymes (17) (18) (19) , including phosphatidyltransferases, poxvirus envelope proteins, a Yersinia murine toxin, and several endonucleases, including Nuc (20) . Mutation of the HKD motifs residing in region I or IV renders human PLD1 and mouse PLD2 inactive (21) . Studies of Nuc also suggest that the histidine in the HKD domain is directly involved in the catalytic reaction by forming a phosphoenzyme intermediate (22) . However, the mechanism(s) by which the two HKD domains are organized spatially to form an active catalytic center is not clear. Vaccinia virus protein VP37 is also a member of the PLD superfamily. Mutagenesis studies reveal that the partially conserved HKD motif is essential for its function (21) . Interestingly, although VP37 protein contains only one HKD domain, it can be immunoprecipitated as a dimer (23) . This observation raises the intriguing possibility that the two HKD motifs in PLD can be brought together to form a single active site by self-association.
In this study, we generated a series of truncated rPLD1 mutants that contained either the HKD motif in the N-terminal half (region I) or in the C-terminal half (region IV). We investigated the PLD activity of the truncated fragments alone or in combination and explored the possibility of association of these fragments in COS 7 cells.
EXPERIMENTAL PROCEDURES
Plasmid Construction-The full-length rPLD1 and its series of truncation mutants with coding regions corresponding to amino acids 169 -1036, 320 -1036, 585-1036, 1-584, 169 -584, and 320 -584 were created by polymerase chain reaction amplification. The forward primers to amplify the rPLD1 with coding region starting at amino acid 1, 169, 320, or 585 were 5Ј-GGGGTACCTATGTCACTAAGAAGTGAGGC, 5Ј-GGGGTACCTGAAAATGCAATCCAGGAGG, 5Ј-GGGGTACCTGGAG-GCGCCATCGAGGAG, and 5Ј-GGGGTACCTAACACCGGCTCCATC-CGA, respectively. The reverse primers that were used to amplify the rPLD1 constructs that end either at amino acid 584 or at 1036 were 5Ј-GGCTCTAGATTAGGAGGCGCTGTCGACGCT, and 5Ј-GGCTCTA-GATTAAGTCCAAACCTCCATGGG, respectively. The polymerase chain reaction fragments were then subcloned in frame with the Nterminal express-tag at KpnI/XbaI sites in the polylinker region of the PcDNA 3.1 vector (Invitrogen). All the constructs were sequenced to verify the coding regions of rPLD1.
PLD Assay-COS 7 cells were maintained in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) supplemented with 10% fetal bovine serum in humidified 10% CO 2 . The cells were transfected with FuGENE 6 (Boehringer Mannheim) according to manufacturer's instruction. After overnight serum starvation (0.5% fetal bovine serum in Dulbecco's modified Eagle's medium), PLD assays were carried out (24) .
Subcellular Fractionation-COS 7 cells were harvested after transfection and overnight starvation as described above. The cells were washed twice with ice-cold lysis buffer A (25 mM Hepes, 10% glycerol, 1 mM of EDTA, 1 mM of EGTA, 1 mM dithiothreitol, and 1 mM phenylmethylsulfonyl fluoride and protease inhibitor mixture tablets (Boehringer Mannheim) (1 tablet/50 ml of lysis buffer). The cells were then resuspended in lysis buffer A and passed through 27-gauge needles five times. The cell lysate was then centrifuged at 120,000 ϫ g for 45 min at 4°C to separate the cytosol and the crude membrane fraction. The membrane fraction was washed four times with the lysis buffer A and then passed through a 27-gauge needle until the pellet was resuspended. The Bradford method was used for the quantitation of protein concentration of the cytosol and the membrane fractions.
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Western Blotting-Protein samples were analyzed by SDS-polyacrylamide gel electrophoresis and transferred to membranes (Immobilon-P, Millipore). The blots were blocked with 5% non-fat milk and incubated with the appropriate primary antibodies followed by horseradish peroxidase-conjugated secondary antibody. Immunoreactive bands were detected using enhanced chemiluminescence.
Immunoprecipitation-COS 7 cells cultured on a 100-mm dish were transfected and starved as described above. The cells were washed twice with ice-cold phosphate-buffered saline and then resuspended in the lysis buffer B (25 mM Hepes, 10% glycerol, 50 mM KCl, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 0.1% SDS, 1% Triton X-100, and 1 mM phenylmethylsulfonyl fluoride and the protease inhibitor mixtures described above). The cell suspension was then passed through a 27-gauge needle five times, and the resulting cell lysate centrifuged at 15,000 rpm in an Eppendorf microcentrifuge for 10 min at 4°C to pellet the unbroken cells. The supernatant was then precleared with 1 g of affinity-purified mouse IgG and 20 l of a 1:1 slurry of protein A beads for 1 h at 4°C. The mixture was spun, and the resulting supernatant incubated with 3 l of mouse monoclonal anti-express antibodies (Invitrogen) and 20 l of protein A beads overnight. The immunoprecipitates were washed four times with the lysis buffer B, and the resulting products resuspended in SDS sample buffer and analyzed by Western blotting with monoclonal anti-V5 antibodies (Invitrogen).
RESULTS
Construction of Mutant PLD1-Rat PLD1 (rPLD1) contains four conserved regions with one HKD domain in region I and the other in region IV (Fig. 1) . Mutagenesis of either HKD domain inactivates the enzyme (21) , suggesting the integrity of the HKD domains is essential. In order to directly address this and the possibility that self-association of rPLD is involved in its catalytic mechanism, a series of deletion mutants of rPLD1 containing only one of the HKD motifs were generated and tagged at the N terminus with Express-epitope. As demonstrated in Fig. 1 , the rPLD1 molecule was N-terminally truncated and/or split at amino acid 584 to generate N-or Cterminal fragments. This position was selected because the surrounding amino acids are not conserved or involved in alternative splicing (8, 11) .
rPLD1 Deletion Mutants with Only One HKD Motif Showed No PLD Activity-Full-length or deletion mutants of rPLD1 were expressed in COS 7 cells, and the PLD activity was measured. Although Express-tagged full-length rPLD1 showed activity comparable with that of rPLD1 with no tag, all the deletion mutants that contained only one HKD domain showed no catalytic activity compared with vector ( Fig. 2A) . The lack of PLD activity of the deletion mutants was also observed when cells were incubated with 100 nM PMA, which stimulates PLD through the activation of PKC (1) (Fig. 2B, cf. Fig. 2A) . To explore the possibility that the deletion mutants had no PLD activity because they could not target to the membrane, COS 7 cells expressing wild type or truncated forms of rPLD1 were fractionated into cytosol and crude membranes as described under "Experimental Procedures." The fractions were analyzed by Western blotting with monoclonal anti-Express antibody. Except for a trace amount of the C-terminal fragment rPLD1-(585-1036) present in the cytosol (data not shown), all the deletion mutants of rPLD1 were detected exclusively in the membrane fraction, as was the case for full-length rPLD1 (Fig.  2C) . Thus, rPLD1 deletion mutants that contained only one of the HKD domains were competent to target to membranes.
PLD Activity Can Be Restored by Coexpressing Deletion Mutants Containing the HKD Motif in Region I with a Deletion
Mutant Containing the HKD in Region IV-Although deletion mutants containing only one HKD motif exhibited no PLD activity, it seemed possible that an active catalytic center could be restored when a mutant containing the N-terminal HKD motif was cotransfected with a mutant containing the other HKD domain. To examine this possibility, rPLD1-(1-584), rPLD1-(169 -584), or rPLD1-(320 -584) was cotransfected with rPLD1-(585-1036) in COS 7 cells and the PLD activity measured. Full-length rPLD1 and rPLD1 carrying a 168-or a 319-amino acid deletion at the N terminus were also transfected separately as positive controls. When rPLD1-(1-584) was cotransfected with rPLD1-(585-1036). PLD activity comparable with that of the full-length enzyme was detected (Fig. 3A) . When these cells were treated with PMA, the PLD activity was also stimulated, as seen for the wild type PLD (Fig. 3B) . Restoration of PLD activity was also observed when the deletion mutants rPLD1-(169 -584) and rPLD1-(320 -585) were cotransfected with rPLD1-(585-1036). These combinations exhibited higher basal activity than seen with wild type rPLD1 (Fig. 3A) , but showed no response to PMA (Fig. 3B) . These findings were consistent with earlier observations (15) that these N-terminal deletions increase the basal catalytic activity of the enzyme, but abolish its response to phorbol ester.
The foregoing results indicated that PLD activity required the presence of both HKD motifs and that the N-and Cterminal halves of rPLD1 might interact to bring the two HKD motifs together to form an active catalytic site.
The N-terminal Half of PLD Can Associate with the C-terminal Half-In order to investigate the association between the N-terminal and C-terminal halves of rPLD1, immunoprecipitation was performed. For the convenience of immunoprecipitation and probing, several of the mutants described in Fig. 1 were generated as C-terminal V5-tagged constructs. These included rPLD1-(1-584)-V5, rPLD1-(169 -584)-V5 and rPLD1-(320 -585)-V5. We first examined whether these V5-tagged deletion mutants could also reconstruct the PLD activity when cotransfected with the Express-tagged rPLD-(585-1036) in COS 7 cells. In fact, PLD activity comparable with that of the full-length enzyme was reconstructed (data not shown), suggesting that the V5-tagged N-terminal fragments were able to form a functional complex with the Express-tagged C-terminal half of the enzyme. The immunoprecipitation experiments were designed to examine whether the N-terminal fragments of rPLD1 tagged with V5 epitope could be immunoprecipitated by anti-Express antibodies, which recognize the C-terminal portion of rPLD1 tagged with Express peptide (Exp-rPLD1-(585-1036)). The COS 7 cells were transfected, and the cell lysates were immunoprecipitated with anti-Express antibodies and analyzed by Western blotting with V5 antibodies. When control experiments were carried out in which Exp-rPLD1-(585-1036) was cotransfected with either the vector or a nonspecific plasmid expressing a V5-tagged ␤-galactosidase (LacZ-V5), no protein band was detected by V5 antibodies. However, when ExprPLD1-(585-1036) was cotransfected with rPLD1-(1-584)-V5 or with rPLD1-(320 -584)-V5, proteins corresponding to the sizes of rPLD1-(1-584)-V5 (ϳ66 kDa) and rPLD1-(320 -584)-V5 (ϳ33 kDa) were detected by V5 antibodies, respectively.
2 Thus the N-terminal portion of rPLD can associate with its C-terminal portion in vivo.
DISCUSSION
All PLD genes isolated to date contain two copies of the HKD motif, with one in the N-terminal half of the enzyme and the other in the C-terminal half (17) . In this study, we utilized deletion mutagenesis to generate a series of rPLD1 mutants to investigate the molecular basis of the PLD function. By transient transfection of COS 7 cells, we found truncated mutants of rPLD that contained only one HKD domain exhibited no transphosphatidylation activity, although all the mutants targeted the membrane fraction. However, PLD activity was restored when the N-and C-terminal halves of rPLD1 that con- 2 The coimmunoprecipitation of rPLD1-(169 -584)-V5 and ExprPLD1-(585-1036) was not performed, since the apparent molecular weight of rPLD1-(169 -584)-V5 is very close to that of IgG and can be barely separated by SDS-polyacrylamide gel electrophoresis.
FIG. 2. Localization and PLD activity of full-length and deletion mutants of rPLD1 expressed in COS 7 cells.
A, the full-length or truncated forms of rPLD1 with or without N-terminal Express-tag were expressed in COS 7 cells. The PLD activity was represented by the percentage of the total radioactivity in the cells that was incorporated into PtdBut. The results are representative of two experiments performed in triplicate. Averages of three determinations are shown. RPLD1 with no tag is represented by "WT-rPLD1". All the other rPLD1 constructs were N-terminally tagged. B, the PLD activity of cells expressing full-length or truncation mutants was measured in the presence of 100 nM PMA. After COS 7 cells were incubated with 0.3% of 1-butanol for 15 min, PMA was added to a final concentration of 100 nM for 50 min before the PLD assay was terminated. C, localization of full-length or deletion mutants of rPLD1 in COS 7 cells. Cells were lysed and fractionated as described under "Experimental Procedures." The cytosol and the crude membrane fractions were analyzed on 4 -12% SDS-polyacrylamide gels followed by Western blotting with monoclonal antibody against Express-tag. tained the different HKD domains were coexpressed. Thus, the N-and C-terminal halves of rPLD1 were able to form a structure that exhibited catalytic activity. By immunoprecipitation experiments, we found that the N-and C-terminal portions of rPLD1 became physically associated in vivo. These results indicate that PLD activity requires the presence and association of the HKD domains from both the N-and C-terminal halves of the enzyme.
PLD is a membrane-associated protein, but the domain involved in the membrane interaction has not been defined. In this study, we found that deletion mutants of rPLD1 that contain only the N-or C-terminal portion of rPLD1 molecule were able to target to the membrane fraction. These results suggest that the interaction of PLD with membrane may be mediated by two or more domains. It is interesting to note that the negatively charged lipid phosphatidylinositol 4,5-bisphosphate is an essential cofactor for PLD (9, 14, 27) , and the ionic interaction between this lipid and polybasic amino acids has been reported to be involved in membrane and protein associations (25, 26) . Thus this mechanism may be involved in the association of PLD with membranes.
Immunoprecipitation experiments showed that the N-and C-terminal halves of rPLD1 interacted in vivo, but the nature of the interaction and the domains involved are not clear. The association between the two halves probably does not require other protein factors, since homogeneous recombinant rPLD1 is active to hydrolyze phosphatidylcholine when appropriate lipid components are supplemented in vitro (8, 14) . Thus, the N-terminal portion of rPLD1 most likely directly interacts with its C-terminal portion, namely, rPLD1 self-associates. This does not, of course, exclude the possibility that the association could be regulated by another protein(s) in vivo. Since coexpression of rPLD1-(169 -584) or rPLD1-(320 -584) with rPLD-(585-1036) could restore the PLD activity and imunoprecipitation experiments showed that rPLD-(320 -584) can interact with rPLD1-(585-1036) (Fig. 4) , the domain in the N-terminal part that is essential for the interaction with the C-terminal portion cannot be located in the first 319 amino acids, but more detailed molecular characterization is required to define its location and that of the interaction site in the C-terminal region.
Our previous studies of rPLD1 showed that deletion of the first 168 or 319 amino acids of rPLD1 did not abolish, but indeed enhanced the basal activity of the enzyme (15) . However, no response to PMA treatment or PKC-␣ was observed (15) . Thus it was proposed that amino acids at the N-terminal end of rPLD1 were likely involved in regulation by PKC (15) . This conclusion was again reached in the present study using a different approach. When rPLD1-(169 -584), or rPLD1-(320 -584), was coexpressed with rPLD1-(585-1036) in COS 7 cells, the high basal PLD activity was reconstructed (Fig. 3A) . However, no further stimulation of the reconstructed PLD activity was observed when PMA was added (Fig. 3B) . Thus a sequence in the N-terminal end of rPLD1 appears to contain an inhibitory element for PLD activity that can be relieved by direct interaction with or phosphorylation by PKC.
The self-association of rPLD1 found in this study may be a general mechanism employed by members of the superfamily to construct an active catalytic center. Most of the enzymes in the PLD superfamily contain two HKD motifs (17) (18) (19) , and the motifs are essential for catalytic function. Thus, it is likely that the two copies of HKD domains are brought together to form an active catalytic site through the self-association. Since the Nterminal half and C-terminal half of rPLD1 can interact, it is possible that rPLD1 can dimerize through a "head to tail" interaction. Thus, the two HKD motifs could be brought together by intra-or intermolecular interactions of rPLD1. These two possible interactions of rPLD1 could be regulated and PLD could function as a monomer or dimer in vivo. Further molecular, biochemical, and structural characterization is necessary to define the functional domains of PLD that participate in membrane association, dimerization, catalytic activity, and interactions with different effectors.
